CDKN2A and neoplasm: The tumour suppressor P16 acts as a tumour suppressor that inhibits the cyclin-dependent kinase 2A, resulting in cell cycle arrest, and consequently, promoter methylation of P16 consequently results in cell growth and proliferation.